Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803—A Report From the Children's Oncology Group
Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.29.0247
Full Text
Open PDFAbstract
Available in full text
Date
September 20, 2010
Authors
Publisher
American Society of Clinical Oncology (ASCO)